SARS-COV-2 Delta variant displays moderate resistance to neutralizing antibodies and spike protein properties of higher soluble ACE2 sensitivity, enhanced cleavage and fusogenic activity.

Neerukonda, Sabari Nath; Vassell, Russell; Lusvarghi, Sabrina; Wang, Richard; Echegaray, Fernando; Bentley, Lisa; Eakin, Ann E; Erlandson, Karl J; Katzelnick, Leah C; Weiss, Carol D; Wang, Wei

Neerukonda, Sabari Nath; Vassell, Russell; Lusvarghi, Sabrina; Wang, Richard; Echegaray, Fernando; Bentley, Lisa; Eakin, Ann E; Erlandson, Karl J; Katzelnick, Leah C; Weiss, Carol D; Wang, Wei.

bioRxiv ; 2021 Nov 08.

Article in En | MEDLINE | ID: mdl-34790980

Fulltext

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597883
https://dx.doi.org/10.1101/2021.11.05.467523

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies Language: En Journal: BioRxiv Year: 2021 Document type: Article

Fulltext

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597883
https://dx.doi.org/10.1101/2021.11.05.467523

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies Language: En Journal: BioRxiv Year: 2021 Document type: Article